Abstract

Natural killer (NK) cell activation is controlled by a balance of activating and inhibitory signals and cytokines such as IL-15. We previously identified cytokine-inducible SH2-containing protein (CIS) as a negative regulator of IL-15 signaling in NK cells under inflammatory conditions. While the functional effect of Cish-deficiency in NK cells was obvious by their increased anti-tumor immunity and hyper-proliferative response to IL-15, it remained unclear how CIS regulates NK cell biology in steady-state. Here, we investigated the role of CIS in the homeostatic maintenance of NK cells and found CIS-ablation promoted terminal differentiation of NK cells and increased turnover, suggesting that under steady-state conditions, CIS plays a role in maintaining IL-15 driven regulation of NK cells in vivo. However, hyper-responsiveness to IL-15 did not manifest in NK cell accumulation, even when the essential NK cell apoptosis mediator, Bcl2l11 (BIM) was deleted in addition to Cish. Instead, loss of CIS conferred a lower activation threshold, evidenced by augmented functionality on a per cell basis both in vitro and in vivo without prior priming. We conclude that Cish regulates IL-15 signaling in NK cells in vivo, and through the rewiring of several activation pathways leads to a reduction in activation threshold, decreasing the requirement for priming and improving NK cell anti-tumor function. Furthermore, this study highlights the tight regulation of NK cell homeostasis by several pathways which prevent NK cell accumulation when IL-15 signaling and intrinsic apoptosis are dysregulated.

Highlights

  • Natural killer (NK) cells are bone marrow (BM) derived lymphocytes that circulate through blood and lymphoid tissues, acting as sentinels of the immune system [1]

  • We observed a significant increase in the proportion of mature, M2 NK cells in the spleen of Cish−/− mice, and this resulted in a compensatory reduction in frequency of M1 and immature stage CD11b−KLRG1− (Imm) subsets when compared to Cish+/+ mice (Figure 1C)

  • NK cell homeostasis is a tightly controlled event that encompasses a number of complex processes and signaling events

Read more

Summary

Introduction

NK cells are bone marrow (BM) derived lymphocytes that circulate through blood and lymphoid tissues, acting as sentinels of the immune system [1]. Their role in protection against cancer has been explored and studies have found increased incidence of cancer in mice and humans that lack NK cells or possess reduced NK cell cytotoxicity [2,3,4]. Utilizing NK cells in clinical settings such as adoptive cell therapy and chimeric antigen receptor (CAR) engineered cells reduces the incidence of severe cytokine release syndrome (CRS) and graft-versus-host disease (GvHD) side effects [6,7,8]. Improving patient outcomes without contributing to severe side-effects have been the driving force behind improving NK cell immunotherapies and as such, a more comprehensive understanding of the mechanisms regulating NK cell homeostasis have indefinite clinical implications

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call